Earlier this week, Robert F. Kennedy Jr. was confirmed as secretary of Health and Human Services amid many resignations at federal health agencies and cancellations of NIH and NCAB meetings. All of this happened at a time when the Trump administration is reportedly preparing to fire thousands of HHS workers.
The NCI Board of Scientific Advisors approved four new concepts and five reissue concepts at a joint meeting of the BSA and the National Cancer Advisory Board Dec. 2-3.
NCI Director Kimryn Rathmell has released her professional judgment budget proposal, requesting nearly $11.5 billion—the same amount as last year’s proposal prepared by her predecessor, Monica Bertagnolli.
Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.
As the likelihood of a flat budget increases for the 2024 fiscal year, NCI will have difficulty maintaining its current programs, the institute’s new director Kimryn Rathmell said in her inaugural NCI director’s report to members of the National Cancer Advisory Board Feb. 8.
The gridlock in Washington is taking a toll on federally funded cancer research as the partisan wrangling in Congress over border security and funding for Israel and Ukraine shows no sign of relenting.
The Office of the Secretary of Health and Human Services is coordinating a health informatics initiative—as part of the Cancer Moonshot—to set common data standards that could be used across key federal health agencies, including NCI, NIH, and FDA.
The probability of NCI receiving a boost in funds over the next two years is slim, NCI Director Monica Bertagnolli said at the joint meeting of the National Cancer Advisory Board and Board of Scientific Advisors June 14.
NCI has released the language of the much-discussed National Cancer Plan, an eight-goal blueprint that spans the spectrum of cancer care—prevention, treatment, and survivorship—to correspond with President Joe Biden’s vision of cutting cancer mortality by half in 25 years.
John D. Carpten was named director of City of Hope Comprehensive Cancer Center, director of Beckman Research Institute of City of Hope, and chief scientific officer.
